Table 1.
Summary of the differential metabolites in GEM-S/R pancreatic tumor-bearing mice treated with GEM-based chemotherapy.
| Name | Group |
Molecular formula |
Ion (m/z) | RT/min | ESI mode |
|---|---|---|---|---|---|
| l-Arginine | AA-1 | C6H14N4O2 | 173.1022 | 1.55 | M – H |
| l-Glutamine | AA-2 | C5H10N2O3 | 145.0612 | 1.60 | M – H |
| l-Kynurenine | AA-3 | C10H12N2O3 | 207.0760 | 2.92 | M – H |
| l-Methionine | AA-4 | C5H11NO2S | 150.0582 | 2.21 | M + H |
| l-Phenylalanine | AA-5 | C9H11NO2 | 164.0715 | 3.45 | M – H |
| l-Threonine | AA-6 | C4H9NO3 | 118.0503 | 1.58 | M – H |
| L-Tryptophan | AA-7 | C11H12N2O2 | 205.0972 | 3.69 | M + H |
| l-Tyrosine | AA-8 | C9H11NO3 | 182.0809 | 2.82 | M + H |
| Acetyl-l-carnitine | AC-1 | C9H17NO4 | 204.1228 | 1.66 | M + H |
| Butyryl-l-carnitine | AC-2 | C11H21NO4 | 232.1539 | 3.27 | M + H |
| Decanoyl-l-carnitine | AC-3 | C17H33NO4 | 316.2473 | 5.58 | M + H |
| Decenoyl-l-carnitine | AC-4 | C17H31NO4 | 314.2314 | 5.46 | M + H |
| Dodecanoyl-l-carnitine | AC-5 | C19H37NO4 | 344.2788 | 5.68 | M + H |
| Glutaryl-l-carnitine | AC-6 | C12H21NO6 | 276.1417 | 2.91 | M + H |
| Hexadecanoyl-l-carnitine | AC-7 | C23H45NO4 | 400.3449 | 7.79 | M + H |
| Hexadecenoyl-l-carnitine | AC-8 | C23H43NO4 | 398.3264 | 7.02 | M + H |
| Hexanoyl-l-carnitine | AC-9 | C13H25NO4 | 260.1845 | 4.00 | M + H |
| Hexenoyl-l-carnitine | AC-10 | C13H23NO4 | 258.1699 | 5.29 | M + H |
| l-Carnitine | AC-11 | C7H15NO3 | 162.1125 | 1.60 | M + H |
| Octadecadienyl-l-carnitine | AC-12 | C25H45NO4 | 424.3411 | 7.40 | M + H |
| Octadecanoyl-l-carnitine | AC-13 | C25H49NO4 | 428.3724 | 9.17 | M + H |
| Octadecenoyl-l-carnitine | AC-14 | C25H47NO4 | 426.3569 | 8.21 | M + H |
| Tetradecadienyl-l-carnitine | AC-15 | C21H37NO4 | 368.2785 | 5.64 | M + H |
| Tetradecanoyl-l-carnitine | AC-16 | C21H41NO4 | 372.3096 | 6.62 | M + H |
| Tetradecenoyl-l-carnitine | AC-17 | C21H39NO4 | 370.2954 | 6.09 | M + H |
| Valeryl-l-carnitine | AC-18 | C12H23NO4 | 246.1699 | 3.58 | M + H |
| (Iso)leucyl-phenylalanine | DP-1 | C15H22N2O3 | 279.1746 | 2.11 | M + H |
| Glycyl-phenylalanine | DP-2 | C11H14N2O3 | 221.0916 | 3.59 | M – H |
| Histidinyl-cysteine | DP-3 | C9H14N4O3S | 259.0889 | 1.93 | M + H |
| (±)4-HDoHE | FA-1 | C22H32O3 | 343.2267 | 8.22 | M – H |
| (±)5-HETE | FA-2 | C20H32O3 | 319.2220 | 11.62 | M – H |
| (R)-3-Hydroxy-hexadecanoic acid | FA-3 | C16H32O3 | 271.2264 | 8.19 | M – H |
| 20-OH-LTB4 | FA-4 | C20H32O4 | 335.2218 | 7.28 | M – H |
| 9-Octadecenoic acid | FA-5 | C18H33FO2 | 345.2425 | 9.10 | M + FA – H |
| Arachidonic acid | FA-6 | C20H32O2 | 303.2322 | 10.76 | M – H |
| Docosahexaenoic acid | FA-7 | C22H32O2 | 327.2323 | 10.60 | M – H |
| EPA | FA-8 | C20H30O2 | 301.2163 | 10.22 | M – H |
| 1-Linoleoyl glycerophosphocholine | LPC-1 | C26H50NO7P | 520.3404 | 7.61 | M + H |
| LysoPC(14:0) | LPC-2 | C22H46NO7P | 468.3106 | 9.53 | M + H |
| LysoPC(16:0) | LPC-3 | C24H50NO7P | 496.3402 | 8.46 | M + H |
| LysoPC(17:0) | LPC-4 | C25H52NO7P | 554.3449 | 9.23 | M + FA – H |
| LysoPC(18:0) | LPC-5 | C26H54NO7P | 524.3716 | 10.17 | M + H |
| LysoPC(18:2) | LPC-6 | C26H50NO7P | 564.3309 | 7.62 | M + FA – H |
| LysoPC(20:3) | LPC-7 | C28H52NO7P | 568.3404 | 7.86 | M + Na |
| LysoPC(20:4) | LPC-8 | C28H50NO7P | 588.3302 | 7.61 | M + FA – H |
| LysoPC(20:5) | LPC-9 | C28H48NO7P | 542.3233 | 7.13 | M + H |
| LysoPC(22:6) | LPC-10 | C30H50NO7P | 612.3300 | 7.52 | M + FA – H |
| LysoPC(P-16:0) | LPC-11 | C24H50NO6P | 524.3342 | 8.79 | M + FA – H |
| PC(O-16:0/0:0) | LPC-12 | C23H48NO7P | 482.3235 | 10.87 | M + H |
| LysoPE(0:0/20:5) | LPE-1 | C25H42NO7P | 500.2783 | 7.06 | M + H |
| LysoPE(20:2) | LPE-2 | C25H48NO7P | 504.3077 | 7.62 | M – H |
| Succinoadenosine | NuA | C14H17N5O8 | 382.0974 | 2.94 | M – H |
| Uridine | NuC | C9H12N2O6 | 245.0732 | 1.93 | M + H |
| 2-Methyl-3-hydroxypropanoate | OA-1 | C4H8O3 | 103.0401 | 2.69 | M – H |
| 3-Hydroxyadipic acid | OA-2 | C6H10O5 | 161.0442 | 1.57 | M – H |
| 3-Indolelactic acid | OA-3 | C10H9NO | 204.0659 | 4.03 | M + FA – H |
| Citric acid | OA-4 | C6H8O7 | 191.0193 | 2.17 | M – H |
| Fumaric acid | OA-5 | C4H4O4 | 115.0035 | 2.30 | M – H |
| Gluconic acid | OA-6 | C6H12O7 | 195.0498 | 1.64 | M – H |
| l-2-Aminoadipic acid | OA-7 | C6H11NO4 | 162.0760 | 2.84 | M + H |
| Lactic acid | OA-8 | C3H6O3 | 91.0396 | 2.17 | M + H |
| l-Glutamate | OA-9 | C5H9NO4 | 146.0462 | 2.05 | M – H |
| Malic acid | OA-10 | C4H6O5 | 133.0142 | 1.89 | M – H |
| Pyrroline hydroxycarboxylic acid | OA-11 | C5H7NO3 | 130.0505 | 1.57 | M + H |
| Uric acid | OA-12 | C5H4N4O3 | 169.0353 | 2.39 | M + H |
| (10E)-9-Oxo-10-hexadecenoic acid | Others-1 | C16H28O3 | 269.2111 | 8.01 | M + H |
| Succinic anhydride | Others-2 | C4H4O3 | 101.0239 | 2.80 | M + H |
| PE(20:0/20:4) | PE-1 | C45H82NO8P | 840.5732 | 8.66 | M + FA – H |
| PE(P-18:0/0:0) | PE-2 | C23H48NO6P | 464.3131 | 10.35 | M – H |
| 1-[(5-Amino-5-carboxypentyl)amino]−1-deoxyfructose | Sca-1 | C12H24N2O7 | 353.1441 | 10.77 | M + FA – H |
| D-galactose | Sca-2 | C6H12O6 | 179.0552 | 1.57 | M – H |
| 3α,7α-Dihydroxy-5beta-cholestan-26-al | ST-1 | C26H42O4 | 463.3055 | 5.34 | M + FA – H |
| 7α-Hydroxycholest-4-en-3-one | ST-2 | C27H44O2 | 445.3314 | 11.80 | M + FA – H |
| Chenodeoxycholate | ST-3 | C24H40O4 | 391.2832 | 6.80 | M – H |
| Glycocholate | ST-4 | C26H43NO6 | 466.3166 | 10.96 | M + H |
RT, retention time; ESI, electrospray ionization.